Latigo Biotherapeutics, Inc.

LTGOReported to SECin USCIK 0002056611Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 69. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 69
Form 4 lines at Latigo Biotherapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
5AM Ventures VI, L.P.—Conversionnothing paid1,484,401 sharesAug 12, 20265AM Ventures VI, L.P.nothing paidConversion · Aug 12Conversion1,484,401Aug 12, 2026
5AM Ventures VI, L.P.—Conversionnothing paid866,018 sharesAug 12, 20265AM Ventures VI, L.P.nothing paidConversion · Aug 12Conversion866,018Aug 12, 2026
5AM Ventures VI, L.P.—Conversionnothing paid1,823,238 sharesAug 12, 20265AM Ventures VI, L.P.nothing paidConversion · Aug 12Conversion1,823,238Aug 12, 2026
5AM Ventures VI, L.P.—Conversionnothing paid3,152,305 sharesAug 12, 20265AM Ventures VI, L.P.nothing paidConversion · Aug 12Conversion3,152,305Aug 12, 2026
5AM Ventures VI, L.P.—Conversion—2,350,419 sharesAug 12, 20265AM Ventures VI, L.P.—Conversion · Aug 12Conversion2,350,419Aug 12, 2026